Cryotherapy as an adjuvant in the treatment with vismodegib for local advanced nonsurgical basal cell carcinoma: a report of 8 cases

Introduction: Basal cell carcinoma (BCC) is the most prevalent skin cancer worldwide. The most frequently used treatment for BCC is surgical resection. Lately, there are other options for nonsurgical BCC such as hedgehog pathways inhibitors, which is indicated in patients whose cancer is locally adv...

Full description

Autores:

Castillo Molina, David
Fierro Lozada, Jesus Daniel
García C., Ana María
Molano Pérez, Manuela Alejandra
Cantillo Avilez, Melissa
Guerrero Roncancio, Laura
Muñoz-Ordoñez, Sara
Campo Slebi, Isabella
ALVIS-ZAKZUK, NELSON J.
Castillo Saavedra, David E.
Martinez Zuñiga, Diego M.
Alvis Zakzuk, Nelson J.

Tipo de recurso:

Article of journal

Fecha de publicación:

2021

Institución:

Corporación Universidad de la Costa

Repositorio:

REDICUC - Repositorio CUC

Idioma:

eng

OAI Identifier:

oai:repositorio.cuc.edu.co:11323/9307

Acceso en línea:

https://hdl.handle.net/11323/9307
https://doi.org/10.1016/j.jaad.2021.06.541
https://repositorio.cuc.edu.co/

Palabra clave:

Cryotherapy
Vismodegib
Basal cell carcinoma

Rights

openAccess

License

© 2021 Published by Elsevier Inc.